Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine.

doi:10.1038/tpj.2011.28

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine.

The pharmacogenomics journal - 1 Dec 2012

Ono S, Suzuki Y, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Someya T

Abstract excerpt

Several studies have shown increased rates of hyperglycemia and diabetes in schizophrenic patients treated with olanzapine. However, the underlying mechanism is poorly understood. Glucose-dependent insulinotropic polypeptide (GIP) is known to affect insulin secretion by pancreatic β cells. Recently, a meta-analysis study reported an association between a GIP receptor (GIPR) gene polymorphism (rs10423928) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Area Under Curve

Share to Benzodiazepines

Share to C-Peptide

Share to Glucose Tolerance Test

Share to Insulin

Share to Olanzapine

Share to Schizophrenia

Source

Open in PubMed

Identifiers

PMID: 21747410
DOI: 10.1038/tpj.2011.28

Genes

GIPR
GIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine.PMID 21747410Read ↗

GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.Semantic proximity Read ↗

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.Semantic proximity Read ↗

Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentSemantic proximity Read ↗

Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic PatientsSemantic proximity Read ↗

Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.Semantic proximity Read ↗

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.Semantic proximity Read ↗

Regulation of melanocortin-4-receptor (MC4R) expression by SNP rs17066842 is dependent on glucose concentration.Semantic proximity Read ↗

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.Semantic proximity Read ↗

Genetic Correlates of Olanzapine-Induced Weight Gain in Schizophrenia Subjects from North India: Role of Metabolic Pathway GenesSemantic proximity Read ↗

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine.Semantic proximity Read ↗

Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study.Semantic proximity Read ↗

The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala Polymorphism in Patients with SchizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.